His primary areas of study are Cancer research, Internal medicine, Immunology, Molecular biology and DNA methylation. His Cancer research research integrates issues from Downregulation and upregulation, Kinase activity, microRNA, Lymphoma and Tumor suppressor gene. The concepts of his Internal medicine study are interwoven with issues in Surgery, Oncology and Cardiology.
The Surgery study combines topics in areas such as Adverse effect, Clinical trial and Multiple myeloma. His Immunology study combines topics from a wide range of disciplines, such as Progenitor cell, Stem cell and Ischemia. Felipe Prosper interconnects Methylation, Epigenetics and B cell in the investigation of issues within DNA methylation.
His scientific interests lie mostly in Cancer research, Internal medicine, Multiple myeloma, Cell biology and Stem cell. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer, Epigenetics, Immunology and DNA methylation. His study in DNA methylation is interdisciplinary in nature, drawing from both Molecular biology, Methylation and B cell.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery, Oncology and Cardiology. His Multiple myeloma research incorporates elements of Bone marrow and Circulating tumor cell. The study incorporates disciplines such as Bioinformatics and Adult stem cell in addition to Stem cell.
His primary scientific interests are in Cancer research, Multiple myeloma, Internal medicine, Epigenetics and Cell biology. His Cancer research research is multidisciplinary, incorporating elements of Cell, Haematopoiesis, Cell growth, B cell and Immunotherapy. The various areas that Felipe Prosper examines in his Multiple myeloma study include Circulating tumor cell, Transcriptome, Computational biology, Bone marrow and Transplantation.
His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology. Felipe Prosper interconnects Regulation of gene expression, Histone, DNA and DNA methylation in the investigation of issues within Epigenetics. His Cell biology research incorporates themes from Enhancer, Gene expression, Phenotype, Chromatin and Fibrosis.
His primary areas of investigation include Cancer research, Cell biology, Bone marrow, Multiple myeloma and Epigenetics. His biological study focuses on Myeloid leukemia. His Cell biology research is multidisciplinary, incorporating elements of Plasma cell, Gene expression, Phenotype, Chromatin and Fibrosis.
The subject of his Multiple myeloma research is within the realm of Internal medicine. Felipe Prosper has researched Internal medicine in several fields, including Differential diagnosis, Immunophenotyping and AL amyloidosis. His studies in Epigenetics integrate themes in fields like DNA methylation, Hepatic stellate cell, Histone, Enhancer and Regulation of gene expression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
Vanessa Monteil;Hyesoo Kwon;Patricia Prado;Astrid Hagelkrüys.
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study
María-Victoria Mateos;María-Victoria Mateos;José-M. Hernández;José-M. Hernández;Miguel-T. Hernández;Miguel-T. Hernández;Norma-C. Gutiérrez;Norma-C. Gutiérrez.
Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation
Olga Gutierrez;Carlos Pipaon;Naohiro Inohara;Ana Fontalba.
Journal of Biological Chemistry (2002)
Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL
Machiko Horita;Enrique Jose Andreu;Adalberto Benito;Cristina Arbona.
Journal of Experimental Medicine (2000)
Epigenetic regulation of microRNA expression in colorectal cancer
Eva Bandres;Xabier Agirre;Nerea Bitarte;Natalia Ramirez.
International Journal of Cancer (2009)
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
María-Victoria Mateos;Miguel-Teodoro Hernández;Pilar Giraldo;Javier de la Rubia.
The New England Journal of Medicine (2013)
Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.
Jesús Herreros;Felipe Prósper;Ana Perez;Juan J Gavira.
European Heart Journal (2003)
Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
Maite Silva;Adalberto Benito;Cristina Sanz;Felipe Prosper.
Journal of Biological Chemistry (1999)
A DNA methylation fingerprint of 1628 human samples
Augustin F. Fernandez;Yassen Assenov;Jose Ignacio Martin-Subero;Balazs Balint.
Genome Research (2012)
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Xabier Agirre;Amaia Vilas-Zornoza;Antonio Jiménez-Velasco;José Ignacio Martin-Subero.
Cancer Research (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: